Clinical trial

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterCompletedPhase 1Started Apr 1, 200412 enrolledUnited StatesNCT00302744

Abstract

Psychiatric Research Study For Cancer Patients The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAnxiety

Keywords

DepressionMoodCancerQuality of LifePsychiatricAlternativeLos Angeles

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026

ArticlePsilocybin

Psilocybin biosynthesis enhancement through gene source optimization.

Keller MR, McKinney MG, Sen AK +9

Europe PMC2025

ArticlePsilocybin

The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.

Videira NB, Nair V, Paquet V +1

Europe PMC2024